Oklo insider Caroline Cochran sells 120K shares at ~$39
Oklo’s co-founder and COO, a more-than-10% owner, reported 120,000 shares sold on September 1, 2026 under a pre-adopted Rule 10b5-1 trading plan.
Rhea-AI Filing Summary
Oklo Inc. (OKLO) director, officer and more-than-10% shareholder Caroline Cochran reported multiple sales of Class A common stock on September 1, 2026, totaling 120,000 shares, with reported weighted-average sale prices ranging from $38.08 to $39.15, pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2025.
After these transactions, Cochran reported 398,039 shares held directly, and additional indirect holdings through a grantor retained annuity trust in her name, through her spouse, and through her spouse’s grantor retained annuity trust, as well as large positions held by related family trusts and additional grantor retained annuity trusts.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
Net Seller: 120,000 shares
Net Sell
11 txns
Insider
Cochran Caroline
Role
Co-Founder, COO
Sold
120,000 shs ($4.63M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock F1, F2, F3 | 40,000 | $38.66 | $1.55M |
| Sale | Class A Common Stock F1, F4, F3 | 19,800 | $38.88 | $770K |
| Sale | Class A Common Stock F1, F3 | 200 | $39.15 | $8K |
| Sale | Class A Common Stock F1, F5, F6, F7 | 40,000 | $38.40 | $1.54M |
| Sale | Class A Common Stock F1, F8, F6, F9 | 20,000 | $38.56 | $771K |
| holding | Class A Common Stock F3 | -- | -- | -- |
| holding | Class A Common Stock F3 | -- | -- | -- |
| holding | Class A Common Stock F3 | -- | -- | -- |
| holding | Class A Common Stock F6, F9 | -- | -- | -- |
| holding | Class A Common Stock F6, F9 | -- | -- | -- |
| holding | Class A Common Stock F6, F9 | -- | -- | -- |
Holdings After Transaction:
Class A Common Stock — 398,039 shares (Direct);
Class A Common Stock — 529,479 shares (Indirect, By Caroline Cochran GRAT);
Class A Common Stock — 431,533 shares (Indirect, By Jacob DeWitte);
Class A Common Stock — 496,483 shares (Indirect, By Jacob DeWitte GRAT);
Class A Common Stock — 7,583,085 shares (Indirect, By the Caroline DeWitte Family Trust);
Class A Common Stock — 1,000,000 shares (Indirect, By Caroline DeWitte GRAT No. 2);
Class A Common Stock — 474,011 shares (Indirect, By Caroline DeWitt GRAT No. 3);
Class A Common Stock — 7,851,901 shares (Indirect, By the Jacob DeWitte Family Trust);
Class A Common Stock — 1,000,000 shares (Indirect, By Jacob DeWitte GRAT No. 2);
Class A Common Stock — 506,807 shares (Indirect, By Jacob DeWitte GRAT No.3)
Footnotes (9)
- F1. The sales reported herein were effected pursuant to a Rule 10b5-1 plan adopted on March 31, 2025.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.59- $38.75 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F3. For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.
- F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.75- $39.08 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.08- $38.52 inclusive. The Reporting Person's spouse undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F6. For more information about the equity of the Issuer held by the Reporting Person's spouse, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.
- F7. Represents securities held by the Reporting Person's spouse.
- F8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.52- $38.59 inclusive. The Reporting Person's spouse undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F9. Represents securities beneficially owned by the Reporting Person's spouse.
Key Figures
Total shares sold: 120,000 shares
Direct sale by Caroline Cochran: 40,000 shares at $38.66 per share
Sales by Caroline Cochran GRAT: 19,800 shares at $38.88; 200 shares at $39.15
+3 more
6 metrics
Total shares sold
120,000 shares
Aggregate Class A common stock sales reported for September 1, 2026
Direct sale by Caroline Cochran
40,000 shares at $38.66 per share
Class A common stock sold on September 1, 2026 from direct holdings
Sales by Caroline Cochran GRAT
19,800 shares at $38.88; 200 shares at $39.15
Class A common stock sold on September 1, 2026 by her grantor retained annuity trust
Sales by spouse-related entities
40,000 shares at $38.40; 20,000 shares at $38.56
Class A common stock sold September 1, 2026 by spouse and spouse’s grantor retained annuity trust
Direct holdings after transactions
398,039 shares
Class A common stock reported as held directly after September 1, 2026 sales
Indirect family trust holdings
7,583,085 and 7,851,901 shares
Class A common stock reported in family trusts associated with Caroline Cochran and her spouse
Key Terms
Rule 10b5-1 plan, weighted average price, grantor retained annuity trust, definitive proxy statement
4 terms
Rule 10b5-1 plan regulatory
"The sales reported herein were effected pursuant to a Rule 10b5-1 plan adopted on March 31, 2025."
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
grantor retained annuity trust financial
"By Caroline Cochran GRAT"
A grantor retained annuity trust (GRAT) is an estate-planning tool where the person who creates the trust transfers assets into it but receives fixed cash payments (an annuity) from the trust for a set number of years; whatever remains after that term passes to designated beneficiaries. It matters to investors because it can shift future appreciation of assets out of the creator’s taxable estate—like putting an asset into a timed vending machine that pays you fixed amounts while any extra value that grows inside the machine goes to heirs with reduced gift or estate tax consequences.
definitive proxy statement regulatory
"please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission."
A Definitive Proxy Statement is a detailed document that a company sends to its shareholders before a big meeting, like voting on important decisions. It explains what's being voted on and gives important information so shareholders can make informed choices. It matters because it helps shareholders understand and participate in key company decisions.
FAQ
What insider transactions did OKLO’s Caroline Cochran report on September 1, 2026?
She reported sales of 120,000 shares of Oklo Class A common stock on September 1, 2026, through a combination of direct holdings, her own grantor retained annuity trust, her spouse, and her spouse’s grantor retained annuity trust.
What indirect OKLO holdings associated with Caroline Cochran were reported?
Indirectly, she reported holdings through a grantor retained annuity trust in her name, through her spouse, and through her spouse’s grantor retained annuity trusts and family trusts, including reported positions such as 7,583,085 and 7,851,901 shares in family trusts and 1,000,000-plus share blocks in related grantor retained annuity trusts.
AI-generated analysis. How Rhea-AI works. Not financial advice.
